DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactEarnings

Aristo Bio-Tech And Lifescience Limited — Outcome of Board Meeting

NSE 1 hr ago·7 Sept 2026, 2:44 pm

Aristo Bio-Tech & Lifescience

Aristo Bio-Tech And Lifescience Limited has informed stock exchanges that its board of directors held a meeting on September 7, 2026. The company has submitted the formal outcome of this meeting to the exchange, which is now publicly available for investors to review.

This announcement is a routine corporate disclosure, indicating that the board has convened to discuss and approve various strategic and administrative matters. For retail investors, this update confirms that the company is actively managing its operations and governance, ensuring transparency in its reporting to the market.

Investors should monitor the official exchange filing for any specific resolutions or updates regarding the company's future plans. As this is a standard board meeting outcome, it does not immediately signal any major corporate action, but keeping an eye on subsequent announcements will provide further clarity on the company's trajectory.